Zona pellucida : current status as a candidate antigen for contraceptive vaccine development

The porcine zona pellucida represents a unique immunocontraceptive target antigen. Initial active immunization studies using crude or partially purified zona components as immunogens resulted in adverse, nonreversible effects on ovarian folliculogenesis, but more recent findings in nonhuman primates...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:American journal of reproductive immunology and microbiology : AJRIM. - 1985. - 15(1987), 4 vom: 15. Dez., Seite 122-30
1. Verfasser: Sacco, A G (VerfasserIn)
Format: Aufsatz
Sprache:English
Veröffentlicht: 1987
Zugriff auf das übergeordnete Werk:American journal of reproductive immunology and microbiology : AJRIM
Schlagworte:Journal Article Review Antibodies Antigen-antibody Reactions Biology Contraception Contraception Research Contraception, Immunological Examinations And Diagnoses Family Planning mehr... Female Contraception Genitalia Genitalia, Female Immunity Immunity, Active Immunologic Factors Laboratory Examinations And Diagnoses Ovarian Effects Ovary Physiology Urogenital System Vaccines
Beschreibung
Zusammenfassung:The porcine zona pellucida represents a unique immunocontraceptive target antigen. Initial active immunization studies using crude or partially purified zona components as immunogens resulted in adverse, nonreversible effects on ovarian folliculogenesis, but more recent findings in nonhuman primates indicate that such effects are not as severe and are reversible. Consequently, current efforts are directed toward identifying a zona immunogen that elicits contraceptive antibodies that produce no adverse effects on the ovary. Other studies are in progress to determine optimal injection/immunization format, proper immunogen dosage, and appropriate adjuvant for use in the zona-antizona immunocontraceptive system. Recent data have been very encouraging and emphasize the contraceptive efficacy of this approach to reproduction control
Beschreibung:Date Completed 18.03.1988
Date Revised 04.04.2017
published: Print
Citation Status MEDLINE
ISSN:8755-8920